483 related articles for article (PubMed ID: 26203745)
41. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
Seo MJ; Kim JM; Lee MJ; Sohn YS; Kang KK; Yoo M
Curr Eye Res; 2010 Feb; 35(2):165-75. PubMed ID: 20136427
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.
Žiniauskaite A; Ragauskas S; Hakkarainen JJ; Rich CC; Baumgartner R; Kalesnykas G; Albers DS; Kaja S
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3088-3093. PubMed ID: 30025146
[TBL] [Abstract][Full Text] [Related]
43. The effect of sinomenine eye drops on experimental dry eye in mice.
Li H; Wei F; Li S; Yan L; Lu P
Cutan Ocul Toxicol; 2020 Dec; 39(4):389-395. PubMed ID: 33103493
[TBL] [Abstract][Full Text] [Related]
44. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye.
Lin BW; Chen MZ; Fan SX; Chuck RS; Zhou SY
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):45-53. PubMed ID: 25491293
[TBL] [Abstract][Full Text] [Related]
45. Selenium compound protects corneal epithelium against oxidative stress.
Higuchi A; Inoue H; Kawakita T; Ogishima T; Tsubota K
PLoS One; 2012; 7(9):e45612. PubMed ID: 23049824
[TBL] [Abstract][Full Text] [Related]
46. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
47. Effects of a new lipid tear substitute in a mouse model of dry eye.
Scifo C; Barabino S; De Pasquale G; Blanco AR; Mazzone MG; Rolando M
Cornea; 2010 Jul; 29(7):802-6. PubMed ID: 20489574
[TBL] [Abstract][Full Text] [Related]
48. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560
[TBL] [Abstract][Full Text] [Related]
49. Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye.
Daull P; Nagano T; Gros E; Feraille L; Barabino S; Garrigue JS
Curr Eye Res; 2021 Aug; 46(8):1096-1104. PubMed ID: 33588656
[TBL] [Abstract][Full Text] [Related]
50. Serine protease inhibitor A3K suppressed the formation of ocular surface squamous metaplasia in a mouse model of experimental dry eye.
Lin Z; Zhou Y; Wang Y; Zhou T; Li J; Luo P; He H; Wu H; Liu Z
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5813-20. PubMed ID: 25103264
[TBL] [Abstract][Full Text] [Related]
51. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
[TBL] [Abstract][Full Text] [Related]
52. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
53. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
Shamloo K; Barbarino A; Alfuraih S; Sharma A
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4511-4519. PubMed ID: 31675422
[TBL] [Abstract][Full Text] [Related]
54. Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.
Krauss AH; Corrales RM; Pelegrino FS; Tukler-Henriksson J; Pflugfelder SC; de Paiva CS
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5888-95. PubMed ID: 26348638
[TBL] [Abstract][Full Text] [Related]
55. Amniotic membrane extract ameliorates benzalkonium chloride-induced dry eye in a murine model.
Xiao X; Luo P; Zhao H; Chen J; He H; Xu Y; Lin Z; Zhou Y; Xu J; Liu Z
Exp Eye Res; 2013 Oct; 115():31-40. PubMed ID: 23792171
[TBL] [Abstract][Full Text] [Related]
56. Effect of IRT5 probiotics on dry eye in the experimental dry eye mouse model.
Moon J; Ryu JS; Kim JY; Im SH; Kim MK
PLoS One; 2020; 15(12):e0243176. PubMed ID: 33259525
[TBL] [Abstract][Full Text] [Related]
57. [The protection of hydrogen-rich saline on a rat dry eye model induced by scopolamine hydrobromide].
Chu YY; Hua N; Ru YS; Zhao SZ
Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):363-372. PubMed ID: 28494565
[No Abstract] [Full Text] [Related]
58. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
Zagon IS; Sassani JW; Immonen JA; McLaughlin PJ
Clin Exp Ophthalmol; 2014 Mar; 42(2):159-68. PubMed ID: 23777539
[TBL] [Abstract][Full Text] [Related]
59. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.
Li X; Kang B; Woo IH; Eom Y; Lee HK; Kim HM; Song JS
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3104-3114. PubMed ID: 30025127
[TBL] [Abstract][Full Text] [Related]
60. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
